Chicago Capital’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $39.1M | Sell |
74,297
-3,084
| -4% | -$1.73M | 0.94% | 35 |
|
|
2026
Q1 | $43.5M | Sell |
77,381
-8,003
| -9% | -$5.13M | 1.17% | 29 |
|
|
2025
Q4 | $57.8M | Sell |
85,384
-412
| -0.5% | -$281K | 1.43% | 23 |
|
|
2025
Q3 | $54.8M | Sell |
85,796
-526
| -0.6% | -$319K | 1.35% | 29 |
|
|
2025
Q2 | $46.3M | Sell |
86,322
-977
| -1% | -$467K | 1.14% | 32 |
|
|
2025
Q1 | $36.7M | Buy |
87,299
+1,115
| +1% | +$484K | 1.04% | 35 |
|
|
2024
Q4 | $35.6M | Sell |
86,184
-7,397
| -8% | -$3.24M | 0.94% | 36 |
|
|
2024
Q3 | $47.3M | Sell |
93,581
-136
| -0.1% | -$66.1K | 1.31% | 32 |
|
|
2024
Q2 | $45.7M | Sell |
93,717
-103
| -0.1% | -$51.7K | 1.36% | 30 |
|
|
2024
Q1 | $50.7M | Sell |
93,820
-143
| -0.2% | -$78.1K | 1.54% | 29 |
|
|
2023
Q4 | $52.2M | Buy |
93,963
+2,276
| +2% | +$1.07M | 1.88% | 23 |
|
|
2023
Q3 | $40.1M | Sell |
91,687
-220
| -0.2% | -$110K | 1.88% | 23 |
|
|
2023
Q2 | $46.2M | Sell |
91,907
-729
| -0.8% | -$349K | 2.08% | 20 |
|
|
2023
Q1 | $46.3M | Buy |
92,636
+7,575
| +9% | +$3.63M | 2.3% | 17 |
|
|
2022
Q4 | $34.7M | Buy |
85,061
+18,347
| +28% | +$7.12M | 1.92% | 18 |
|
|
2022
Q3 | $21.7M | Buy |
66,714
+591
| +0.9% | +$217K | 1.26% | 33 |
|
|
2022
Q2 | $23.2M | Buy |
66,123
+46
| +0.1% | +$18.8K | 1.28% | 32 |
|
|
2022
Q1 | $36.1M | Sell |
66,077
-3,647
| -5% | -$1.92M | 1.56% | 29 |
|
|
2021
Q4 | $45.9M | Sell |
69,724
-3,243
| -4% | -$2.04M | 1.71% | 23 |
|
|
2021
Q3 | $45.4M | Sell |
72,967
-1,586
| -2% | -$1.07M | 1.72% | 26 |
|
|
2021
Q2 | $47.1M | Sell |
74,553
-426
| -0.6% | -$235K | 1.84% | 25 |
|
|
2021
Q1 | $36.7M | Sell |
74,979
-15,365
| -17% | -$7.7M | 1.55% | 34 |
|
|
2020
Q4 | $45.2M | Sell |
90,344
-102
| -0.1% | -$45.6K | 2.02% | 21 |
|
|
2020
Q3 | $35.6M | Sell |
90,446
-263
| -0.3% | -$97.2K | 1.83% | 26 |
|
|
2020
Q2 | $29.9M | Sell |
90,709
-270
| -0.3% | -$78.2K | 1.74% | 26 |
|
|
2020
Q1 | $22M | Buy |
90,979
+47
| +0.1% | +$12.3K | 1.78% | 23 |
|
|
2019
Q4 | $23.7M | Sell |
90,932
-85
| -0.1% | -$22.4K | 1.45% | 32 |
|
|
2019
Q3 | $24.8M | Sell |
91,017
-22,324
| -20% | -$6.21M | 1.66% | 29 |
|
|
2019
Q2 | $31.2M | Buy |
113,341
+1,240
| +1% | +$306K | 2% | 18 |
|
|
2019
Q1 | $25.1M | Buy |
112,101
+2,683
| +2% | +$554K | 1.7% | 26 |
|
|
2018
Q4 | $20.4M | Buy |
109,418
+704
| +0.6% | +$144K | 1.66% | 27 |
|
|
2018
Q3 | $27.1M | Buy |
108,714
+7,599
| +8% | +$1.84M | 1.88% | 28 |
|
|
2018
Q2 | $22M | Buy |
101,115
+33,352
| +49% | +$6.87M | 1.78% | 28 |
|
|
2018
Q1 | $13M | Buy |
+67,763
| New | +$12.5M | 1.73% | 27 |
|
Other funds holding IDXX
Chicago Capital's IDXX Position: Q2 2026 in Review
Chicago Capital reduced its Idexx Laboratories (IDXX) stake by 4% in Q2 2026, selling an estimated $1.73M and leaving 74,297 shares worth $39.1M. The position accounts for 0.94% of the portfolio, ranked #35.
Chicago Capital first reported a position in IDXX in Q1 2018 and has held it in 34 quarters since. The position peaked at $57.8M in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Chicago Capital held 74,297 shares of Idexx Laboratories worth $39.1M as of Q2 2026.
- Chicago Capital sold 3,084 Idexx Laboratories shares in Q2 2026, an estimated $1.73M.
- Idexx Laboratories made up 0.94% of Chicago Capital's portfolio in Q2 2026, its #35 holding.
- Chicago Capital first reported a position in Idexx Laboratories in Q1 2018 and has held it in 34 quarters since.
- Chicago Capital's Idexx Laboratories position peaked at $57.8M in Q4 2025.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Chicago Capital's 13F filing for Q2 2026, filed 28 Jul 2026.